--- title: "Eastman Chemical (EMN) Could Be 9% Undervalued On Its Cost Savings Narrative" type: "News" locale: "en" url: "https://longbridge.com/en/news/296708874.md" description: "Eastman Chemical (EMN) is considered approximately 9% undervalued, with a fair value estimate of $81.13 against its recent close of $74.09. This valuation gap is driven by cost reduction initiatives, strategic asset optimization, and disciplined portfolio management expected to improve net margins and ROIC. While the stock has gained momentum recently, risks include softer end-market demand and competition from lower-cost producers." datetime: "2026-08-23T19:52:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296708874.md) - [en](https://longbridge.com/en/news/296708874.md) - [zh-HK](https://longbridge.com/zh-HK/news/296708874.md) generator: "portal-rs" --- # Eastman Chemical (EMN) Could Be 9% Undervalued On Its Cost Savings Narrative ## Recent performance puts Eastman Chemical in focus Eastman Chemical (EMN) has moved onto investor watchlists after a recent share price run that left the stock up about 9% over the past month and roughly 15% year to date. See our latest analysis for Eastman Chemical. The recent 30 day share price return of 8.64% has helped Eastman Chemical regain some momentum after a flat 90 day move, even though the 5 year total shareholder return of 22.54% below zero shows a weaker longer term picture. If you are comparing Eastman Chemical with other materials and industrial names, it can help to broaden the view and see which companies are moving the most in the robotics and automation theme through the 37 robotics and automation stocks For Eastman Chemical, the recent rebound could indicate that investors are reassessing the underlying business rather than just chasing momentum. Has the stock move already captured that shift, or is the valuation still out of step? ## Most Popular Narrative: 8.7% Undervalued On the most followed narrative, Eastman Chemical’s fair value of $81.13 sits above the last close at $74.09, which suggests the recent share price strength still leaves a valuation gap. > *Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end-market demand recovers and utilization rates normalize.* *Read the complete narrative.* Curious what kind of revenue profile, earnings climb, and future P/E the narrative expects from Eastman Chemical to justify that higher fair value tag? **Result: Fair Value of $81.13 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, Eastman Chemical still faces two key risks that could unsettle this narrative if they worsen: softer demand in end markets and pressure from lower cost competitors. Find out about the key risks to this Eastman Chemical narrative. ## Next Steps With Eastman Chemical showing both potential and pressure points, it can help to move quickly and review the full picture for yourself. To balance the optimism against the concerns, start by checking the 4 key rewards and 2 important warning signs. ## Looking for more investment ideas beyond Eastman Chemical? If Eastman Chemical has your attention, do not stop here. Use the Simply Wall St screener tools to pressure test your ideas and uncover fresh opportunities. - Target dependable income by scanning companies that feature 12 dividend fortresses and see which yields line up with your goals. - Hunt for quality at a reasonable price by checking stocks flagged in the 48 high quality undervalued stocks and compare how their metrics stack up. - Prioritize resilience by reviewing companies highlighted in the 75 resilient stocks with low risk scores and see which profiles match your risk comfort. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### Valuation is complex, but we're here to simplify it. Discover if Eastman Chemical might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [EMN.US](https://longbridge.com/en/quote/EMN.US.md) ## Related News & Research - [Van ECK Associates Corp Buys New Shares in Eastman Chemical Company $EMN](https://longbridge.com/en/news/298106109.md) - [Eastman Chemical (EMN) Earnings Beat Puts Its Undervalued Narrative To The Test](https://longbridge.com/en/news/294654213.md) - [Sherwin Williams (SHW) Pulls Back On Valuation Debate, Is The Upside Already Priced In?](https://longbridge.com/en/news/298422661.md) - [3 EV Battery Stocks Linked To Western Demand Starting With Albemarle Stock](https://longbridge.com/en/news/298538141.md) - [Squarepoint Ops LLC Has $10.70 Million Stock Position in Celanese Corporation $CE](https://longbridge.com/en/news/298572022.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**